Literature DB >> 8309317

SURVIVAL--an integrated software package for survival curve estimation and statistical comparison of survival rates of two groups of patients or experimental animals.

M Durisová1, L Dedík.   

Abstract

SURVIVAL, a new integrated software package for survival curve estimation and statistical comparison of survival rates of two censored or uncensored groups of patients or experimental animals, is described and demonstrated. The software is based on the calculation of the Kaplan-Meier estimates of survival curves and utilizes the Mantel-Haenszel and/or Fisher's test for the statistical comparison of the corresponding survival rates. SURVIVAL can be used for statistical evaluation of survival data obtained either on sequentially created or fixed size groups. The software is menu driven to provide a very user friendly tool for analyzing survival data. It may be of great value mainly in clinical use because it automatically enables evaluation of a large set of survival data, sequentially collected in SURVIVAL's own database during a long survival study, with entry and evaluation possible at any time during the study.

Entities:  

Mesh:

Year:  1993        PMID: 8309317

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  9 in total

1.  Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma.

Authors:  Yushen Huang; Wen Luo; Siyun Chen; Hongmei Su; Wuchang Zhu; Yuanyuan Wei; Yue Qiu; Yan Long; Yanxia Shi; Jinbin Wei
Journal:  Front Genet       Date:  2022-05-10       Impact factor: 4.772

2.  Slow skeletal muscle troponin T, titin and myosin light chain 3 are candidate prognostic biomarkers for Ewing's sarcoma.

Authors:  Yajun Deng; Qiqi Xie; Guangzhi Zhang; Shaoping Li; Zuolong Wu; Zhanjun Ma; Xuegang He; Yicheng Gao; Yonggang Wang; Xuewen Kang; Jing Wang
Journal:  Oncol Lett       Date:  2019-11-04       Impact factor: 2.967

3.  A DNA methylation-associated nomogram predicts the overall survival of osteosarcoma.

Authors:  Jun Shi; Daijuan Huang; Gao Zhang; Feng Zhao; Lin Yang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

4.  Identification and Comprehensive Analysis of FREM2 Mutation as a Potential Prognostic Biomarker in Colorectal Cancer.

Authors:  Hanpeng Du; Haiyue Wang; Fandong Kong; Mingjian Wu; Wei Chen; Jin Lyu; Sitong Zhou; Ronghua Yang
Journal:  Front Mol Biosci       Date:  2022-02-18

5.  Pan-Cancer Analysis of Clinical Relevance via Telomere Maintenance Mechanism.

Authors:  Ji-Yong Sung; Jae-Ho Cheong
Journal:  Int J Mol Sci       Date:  2021-10-14       Impact factor: 5.923

6.  Identification of colon tumor marker NKD1 via integrated bioinformatics analysis and experimental validation.

Authors:  Yue Wang; Chunxia Yang; Wenjing Li; Ying Shen; Jianzhong Deng; Wenbin Lu; Jianhua Jin; Yongping Liu; Qian Liu
Journal:  Cancer Med       Date:  2021-09-21       Impact factor: 4.452

7.  Identification and validation of EMT-immune-related prognostic biomarkers CDKN2A, CMTM8 and ILK in colon cancer.

Authors:  Ning Kang; Xiaoli Xie; Xue Zhou; Yijun Wang; Shengxiong Chen; Ran Qi; Ting Liu; Huiqing Jiang
Journal:  BMC Gastroenterol       Date:  2022-04-16       Impact factor: 2.847

8.  Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.

Authors:  Jingjing Xu; Yuan Zhang; Cheng Liu; Ping Yan; Zongguo Yang
Journal:  Int J Med Sci       Date:  2021-08-25       Impact factor: 3.738

9.  Multi-omics landscape of circadian rhythm pathway alterations in Glioma.

Authors:  Chang Zhang; Jiahui Xu; Lijun Chen; Xiaojie Lin
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.